Article metrics

Download PDFPDF

Extended report
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

 

Online download statistics by month:

Online download statistics by month: December 2016 to March 2024

AbstractFullPdf
Dec 20161165032
Jan 20171043665958
Feb 201766267238
Mar 20175298309
Apr 20171284238
May 20172297298
Jun 2017144598374
Jul 2017463460305
Aug 2017259256131
Sep 2017284283217
Oct 2017232233212
Nov 2017194194150
Dec 2017146146135
Jan 2018168168143
Feb 2018200191160
Mar 201832732172
Apr 201821721767
May 201814614751
Jun 201819619971
Jul 201815515552
Aug 201817817955
Sep 201813313393
Oct 201843843895
Nov 2018207207104
Dec 201874974987
Jan 201915415382
Feb 2019127128232
Mar 201912011991
Apr 2019117114198
May 2019999983
Jun 2019808076
Jul 201910297106
Aug 2019919058
Sep 2019797264
Oct 201910590115
Nov 2019988684
Dec 201910410047
Jan 2020897434
Feb 20201269846
Mar 202013010945
Apr 2020746556
May 202012710991
Jun 202013811848
Jul 202011210227
Aug 20201129658
Sep 20201057343
Oct 202017514554
Nov 20201047245
Dec 2020856746
Jan 20211047840
Feb 2021686038
Mar 20211007448
Apr 2021907341
May 2021625437
Jun 2021908448
Jul 2021706840
Aug 2021707044
Sep 202110210057
Oct 2021857358
Nov 2021795749
Dec 2021907145
Jan 2022705439
Feb 2022725435
Mar 2022847044
Apr 20221009451
May 2022998546
Jun 202211110236
Jul 2022746434
Aug 2022998127
Sep 20221018344
Oct 20221139247
Nov 2022967735
Dec 2022786029
Jan 2023714729
Feb 20231189829
Mar 2023907520
Apr 2023675119
May 2023634922
Jun 2023614517
Jul 2023805629
Aug 2023998028
Sep 2023807322
Oct 2023949025
Nov 20231117425
Dec 20231198934
Jan 2024856523
Feb 2024927027
Mar 2024736276
Total12132122937913